This site uses cookies. By using this site you agree to receiving cookies. View Policy.

181%
Raised
£181,000
Investors
329
Target
£100,000
Equity
12.22%
Pre-money valuation
£1,300,000

NGX is the world’s first Genetically Personalised Nutrition shake, bringing personalised nutrition to active everyday athletes. The company's innovative product, which it intends to file a patent for, is set to disrupt the health, fitness and wellness supplements market.

  • Global dietary supplements industry valued at $278 billion by 2024
  • Meal replacement market growing est 7.1% per annum
  • First-mover advantage: World’s First Genetically Personalised Shake
  • Ongoing discussions to partner in U.S and U.A.E to expand

Idea

NGX Investor pitch video.
NGX product family
NGX product family
NGX on tour
NGX on tour

NGX has created the world’s first genetically personalised nutrition shake. In a world in which 2/3 of the population have food allergies or sensitivities, and as the demand for personalisation grows – NGX presents a convenient solution for those leading a busy, active lifestyle looking to optimise their nutrition.

Our nutritionist approved formula is less than the average lean meal @£1.66, vegan-friendly, naturally sourced, allergen-free, environmentally responsible and capitalises on global, macro trends within the millennial and Z generations.

The current global dietary supplements market size globally is $132bn rising to $278 by 2024. The global sports segment is $50bn rising to $80bn by 2024.

To date, NGX has spent 18 months developing our personalised formula, creating our supplier and distribution network to scale, offline sales team through PT network, branding, building an experienced management team alongside an advisory board.

We've had a tester panel that has consumed over 10,000 meals and provided us with positive feedback, offering valuable insights in developing and expanding our product ranges and business model.

As we grow, we aim to develop a range of products from personalised protein bars, meal plans through to integrated wearable tech to enhance our position as the go-to personalised nutrition brand.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the NGX pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

NGX has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Seed Enterprise Investment Scheme (SEIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 50 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.